BGMS (Bio Green Med Solution Inc.) Earnings per share for the last four quarters

Public company logo of Bio Green Med Solution Inc. (BGMS)

Comparable annual EPS TTM growth demonstrates profit dynamics, where 96.30 is the current value of the indicator. Current volatility is driven by patent disputes amid resource shortages. Meanwhile, Bio Green Med Solution Inc (BGMS) maintains its status as a reliable developer of precision inhibitors. Management's strategy relies on creating effective cell cycle regulation agents for tumor therapy.

BGMS cyclacel.com Earnings per share for the last twelve months (11/23/2025 - 11/17/2026)

Bio Green Med Solution Inc. - analytical breakdowns and key metrics (BGMS)

- business market valuation indicators:
Fundamental valuation:Bio Green Med Solution (BGMS)
Signature product of Bio Green Med Solution

When assessing the resilience of Bio Green Med Solution Inc. (BGMS) to market downturns, it is critical to consider whether the company's authority in developing precision inhibitors for oncology translates into tangible financial results. This 12-month YoY earnings per share growth metric measures the rolling annual EPS trend, neutralizing quarterly gaps to confirm operational efficiency and evaluate the risks of entering positions at local peaks.

Competitor analysis for Bio Green Med Solution Inc

Earnings per share for the trailing year GMAB (Genmab US)|EXEL (Exelixis) - Net earnings per share for the last 12 months|NUVL: Earnings per share for the last four quarters|KYMR (Kymera Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ideayabio.com|Earnings per share for the last twelve months Enliven Therapeutics, Inc. (ELVN)|ORIC (ORIC Pharmaceuticals, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) RLAY (Relay Therapeutics Inc)|Net earnings per share for the trailing year Nurix Pharma|Tyra Biosciences Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Verastem|GLUE (Monte Rosa Therapeutics) - Net earnings per share for the last 12 months|CGEM: Earnings per share for the last four quarters|IMRX (immuneering.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months C4 Tx CCCC|Net earnings per share (EPS TTM) BDTX|Repare Therapeutics Inc. - Earnings per share for the last 12 months|PMV Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year KPTI|PPCB: Net earnings per share for the last 12 months|aadibio.com - Earnings per share for the last four quarters|ALRN: Net earnings per share (EPS TTM)|Blueprint Medicines Corp. - Earnings per share for the trailing year|GLYC (GlycoMimetics Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months SpringWorks Therapeutics Inc. SWTX